SCHEMBL997446

SCHEMBL997446

Cc1cc(Nc2c(-c3ccc(F)cc3)nc3n2CCN(CC(C)(N)C=O)C3)cc(C)c1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 13/20 0.53
CYP3A4 P08684 1/20 0.39
TGFBR1 P36897 2/20 0.33
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31
TUBA3E Q6PEY2 1/20 0.31
TUBA1A Q71U36 1/20 0.31
TUBA1C Q9BQE3 1/20 0.31
TUBB6 Q9BUF5 1/20 0.31
TUBB2B Q9BVA1 1/20 0.31
TUBB1 Q9H4B7 1/20 0.31
CSNK1D P48730 1/20 0.31
CSNK1E P49674 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1000957 0.92 KCNH2 (0.57) KCNH2CYP3A4TGFBR1GAAKDM4E
SCHEMBL17626234 0.88 KCNH2 (0.55) KCNH2CYP3A4TGFBR1ALDH1A1
SCHEMBL997844 0.82 KCNH2 (0.50) KCNH2CYP3A4GAAKDM4EUSP2
SCHEMBL997444 0.80 KCNH2 (0.82) KCNH2CYP3A4TGFBR1CSNK1DCSNK1E
SCHEMBL999239 0.78 KCNH2 (0.58) KCNH2CYP3A4TGFBR1TUBB4ATUBB
SCHEMBL1051396 0.76 KCNH2 (0.60) KCNH2CYP3A4GAAKDM4EUSP2
SCHEMBL997932 0.74 KCNH2 (0.63) KCNH2CYP3A4TGFBR1CSNK1DCSNK1E
SCHEMBL2070086 0.72 KCNH2 (0.67) KCNH2CYP3A4GAAMAPTKDM4E
SCHEMBL998969 0.72 KCNH2 (0.60) KCNH2CYP3A4GAAMAPTALDH1A1
SCHEMBL2068098 0.72 KCNH2 (0.84) KCNH2CYP3A4TGFBR1CSNK1DCSNK1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451814-A2 FUSED IMIDAZOLES AND COMPOSITIONS COMPRISING THEM FOR THE TREATMENT OF PARASITIC DISEASES, SUCH AS E.G. MALARIA IRM LLC (BM) 2012-05-16 EP disclosed
WO-2011006143-A2 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES IRM LLC (BM) 2011-01-13 WO disclosed